Market Mover: Onconova (ONTX) Rises at Midday August 5

Equities Staff  |

Onconova Therapeutics Inc (NASDAQ: ONTX) has risen $0.15 (11.81%) and sits at $1.42, as of 12:04:08 est on August 5.

382,565 shares have been traded today.

The Company rose 5.00% over the last 5 days and shares have fallen 5.97% over the last 30 days.

Onconova expects its next earnings on 2022-08-11.

For technical charts, analysis, and more on Onconova visit the company profile.

About Onconova Therapeutics Inc

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.

To get more information on Onconova Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: Onconova Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

These Stocks are Sending a Signal (like Amazon in 2008)
It Isn’t a Recession Until This Group of Economists Says So
What You Should Know About Europe's Energy Wars
Meatless Meats and Smokeless Smokes
Mixed Wireless Recovery at AT&T, Verizon, T-Mobile: Jeff Kagan
The Strong Dollar Is a Problem for Stocks

Market Movers

Sponsored Financial Content